Hostname: page-component-54dcc4c588-hp6zs Total loading time: 0 Render date: 2025-10-07T12:57:53.479Z Has data issue: false hasContentIssue false

Letter to the editor regarding “let’s doff: a gown conservation strategy for multidrug-resistant organism colonization during the COVID-19 pandemic and beyond” by Rowe et al

Published online by Cambridge University Press:  17 September 2025

Mahdee Saleh*
Affiliation:
Lorn and Islands Hospital, Oban, UK

Abstract

Information

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

The recent study by Rowe et al.Reference Rowe, Fox and Leone1 provides timely, real-world insight into the enduring debate around contact precautions (CP) for asymptomatic carriers of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). By analyzing healthcare-associated infection (HAI) outcomes across three time periods, before, during, and after the COVID-19 pandemic, the authors offer an important conclusion: modifying CP to conserve gowns during the pandemic did not result in increased HA-MRSA, HA-VRE, or Clostridioides difficile (HA-CDI) infections.

We commend the authors for producing a robust multicenter data set and applaud the clarity with which they contextualize their results. However, we believe this study also presents an opportunity to go further, beyond retrospective validation, and actively reassess the value, role, and sustainability of CP in routine clinical care.

Contact precautions, as currently defined by the CDC’s 2007 guideline, include gloves and gowns for all room entries when caring for patients colonized or infected with MDROs.Reference Siegel, Rhinehart, Jackson and Chiarello2 The evidence base questioning CP for asymptomatic MDRO colonization continues to grow. As noted by Rowe et al., a 2018 meta-analysisReference Marra, Edmond, Schweizer, Ryan and Diekema3 and subsequent reviewsReference Young, Doernberg, Snedecor and Mallin4 found little infection control benefit from CP in these contexts. Simultaneously, harms to patients, from reduced healthcare worker contact to heightened anxiety and medical errors, are well documented.Reference Abad, Fearday and Safdar5

Yet even as evidence mounts, many institutions revert to CP “by default.” This inertia deserves re-examination, particularly given the significant economic and environmental costs. PPE accounted for £15 billion in UK NHS expenditure during the pandemic,Reference Stiebahl6 and gowns are the single highest contributors to PPE carbon emissions in healthcare.Reference Rizan, Reed and Bhutta7 These externalities are rarely included in infection control cost-benefit analyses, yet they must be, especially if they reframe CP as a high cost, low value practice.

Rowe et al also correctly identify the absence of PPE compliance audits as a limitation. However, this also highlights a systemic issue: CP adherence is assumed, not measured. Numerous studies show PPE protocol fatigue, incorrect doffing, and inconsistent glove use as common challenges even before COVID-19.Reference Gurses, Seidl and Vaidya8 A logical next step would be integrating real-time audit mechanisms alongside infection surveillance to better correlate policy, practice, and outcome.

The pandemic offered an unplanned but invaluable natural experiment: mass CP de-implementation in real time. Like others (eg, Johns Hopkins and University of California systems) who observed no significant increase in HAIs after reducing CP use,Reference Morgan, Murthy and Munoz-Price9,Reference Rubin and Samore10 Rowe et al.’s findings support a broader reimagining of isolation protocols.

To capitalize on this, professional societies such as SHEA and HICPAC could offer updated, tiered CP guidance:

  • For symptomatic infection: maintain CP.

  • For asymptomatic colonization: evaluate local prevalence, resource strain, and patient risk factors.

  • For low-risk units or end-of-life care: consider standard precautions only.

This study should not be viewed simply as justification for a pandemic-era workaround—it’s a springboard for permanent, thoughtful reform. BJC HealthCare’s decision to modify MDRO isolation policies long-term is commendable. Others should follow, not just to improve patient experience, but to align infection control with the pillars of antimicrobial stewardship, environmental sustainability, and equity.

In conclusion, Rowe et al.’s study contributes more than a retrospective validation of modified CP - it offers an invitation to challenge long-held assumptions. The postCOVID era demands we ask: not only do contact precautions work, but are they always worth it?

Author contributions

M.S. conceptualized, drafted, and revised the letter. The author approved the final version for submission.

Financial support

No external funding was received for this work.

Competing interests

The author declares no conflicts of interest.

References

Rowe, KL, Fox, J, Leone, C, et al. Let’s doff: a gown conservation strategy for multidrug-resistant organism colonization during the COVID-19 pandemic and beyond.Antimicrob Steward Healthc Epidemiol 2025;5:e16410.1017/ash.2025.10069CrossRefGoogle Scholar
Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. CDC.10.1016/j.ajic.2007.10.007CrossRefGoogle Scholar
Marra, AR, Edmond, MB, Schweizer, ML, Ryan, GW, Diekema, DJ. Discontinuing contact precautions for MRSA and VRE: a meta-analysis. Infect Control Hosp Epidemiol 2018;39:790803Google Scholar
Young, H, Doernberg, SB, Snedecor, SJ, Mallin, E. Contact precautions for MRSA and VRE: a meta-narrative review.Am J Infect Control 2019;47:692697Google Scholar
Abad, C, Fearday, A, Safdar, N. Adverse effects of isolation in hospitalized patients: a systematic review.J Hosp Infect 2010;76:97102Google ScholarPubMed
Stiebahl, S. The rising cost of PPE in UK healthcare. BMJ. 2023;382:p1492.Google Scholar
Rizan, C, Reed, M, Bhutta, MF. Environmental impact of PPE supplied to health and social care services in England in the first six months of the COVID-19 pandemic. J R Soc Med. 2021;114:25026310.1177/01410768211001583CrossRefGoogle ScholarPubMed
Gurses, AP, Seidl, KL, Vaidya, V, et al. PPE nonadherence and protocol fatigue: lessons from COVID-19.J Patient Saf 2022;18:. e920e926Google Scholar
Morgan, DJ, Murthy, R, Munoz-Price, LS, et al. Reconsidering contact precautions for endemic MRSA and VRE. Infect Control Hosp Epidemiol 2015;36:11631172CrossRefGoogle Scholar
Rubin, MA, Samore, MH. Review of contact precautions for MRSA and VRE. Infect Dis Clin North Am 2020;34:619637Google Scholar